Sandbox Reserved 1093: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Karsten Theis (talk | contribs)
 
(5 intermediate revisions by 3 users not shown)
Line 6: Line 6:
The X-ray structure of LRRTM2 reveals that this transmembrane protein is composed of 3 main domains: a N-terminal leucine rich repeat domain which is extracellular, a single transmembrane domain and a C-terminal cytoplasmic region. The protein is composed of 516 amino acids.
The X-ray structure of LRRTM2 reveals that this transmembrane protein is composed of 3 main domains: a N-terminal leucine rich repeat domain which is extracellular, a single transmembrane domain and a C-terminal cytoplasmic region. The protein is composed of 516 amino acids.


[[Image:LRRTM2 details.png|900px|left]]
[[Image:LRRTM2 details.png|500px|left]]
   
   
'''<scene name='82/829346/Lrrtm2/5'>N-term fixation domain</scene>'''
'''<scene name='82/829346/Lrrtm2/5'>N-term fixation domain</scene>'''
Line 58: Line 58:
The structure of the complex <scene name='82/829346/Complex/1'>Nrxn1β–LRRTM2</scene>[http://proteopedia.org/wiki/index.php/5z8y]is being determined by co-crystallisation. A mutation from His 355 to Ala 355 without affecting the complex structure is necessary to maintain the stability of the crystal.  
The structure of the complex <scene name='82/829346/Complex/1'>Nrxn1β–LRRTM2</scene>[http://proteopedia.org/wiki/index.php/5z8y]is being determined by co-crystallisation. A mutation from His 355 to Ala 355 without affecting the complex structure is necessary to maintain the stability of the crystal.  


PSD-95 [http://proteopedia.org/wiki/index.php/1tq3] is a post synaptic scaffolding protein playing a role in the regulation of the expression of the genes coding for AMPA receptors. This protein also play a role in the translocation of LRRTM2 after the translation.  
PSD-95 [http://proteopedia.org/wiki/index.php/1tq3] is a postsynaptic scaffolding protein playing a role in the regulation of the expression of the genes coding for AMPA receptors. This protein also play a role in the translocation of LRRTM2 after the translation.  
 


'''Other synaptic organisers'''
'''Other synaptic organisers'''


Neuroligins (NLs)[http://proteopedia.org/wiki/index.php/3vkf]
Neuroligins (NLs)[http://proteopedia.org/wiki/index.php/3vkf]
LRRTM2 bind to Neurexins 1, 2 and 3 ︎and ︎a variant region at splice site 4 in the LNS. As the variant region lacking a 30 amino acid insert (-S4), LRRTM2 cannot induce presynaptic differentiation in neurons. On the contrary, <scene name='82/829346/Neurologin-neurexin/1'>Neuroligin1</scene> binds to Neurexins 1, 2, and 3, has a higher affinity with Neurexin 1 (-S4) than with Neurexin 1 (+S4)
LRRTM2 bind to Neurexins 1, 2 and 3 ︎and ︎a variant region at splice site 4 in the LNS. As the variant region lacking a 30 amino acid insert (-S4), LRRTM2 cannot induce presynaptic differentiation in neurons. On the contrary, <scene name='82/829346/Neurologin-neurexin/1'>Neuroligin1</scene> binds to Neurexins 1, 2, and 3, has a higher affinity with Neurexin 1 (-S4) than with Neurexin 1 (+S4). As both Neuroligins and LRRTMs bind to Neurexins, Neuroligins can compensate for reduced LRRTMs functions. Those proteins works in a summative way to enhance the recruitment of presynaptic protein.


== Disease ==


GluD2 [[http://proteopedia.org/wiki/index.php/5cc2]]
Autism Spectrum Disorders (ASDs) is a broad group of various autism disorders such as Asperger, Rett and others development disorders. It is also associated to schizophrenia and Tourette Syndrome. An important number of proteins are implicated in those diseases and only a few are actually been proven to be linked to those disorders. Both neurexins and LRR proteins are good candidates. It have been shown that mutation in Nrxn1 can lead to modification of the LNS fixation site (part that binds to LRRTM2) resulting in autism. It was also demonstrated that mutations in LRR lead to hereditary lateral temporal epilepsy and Parkinson.  


A deletion (240 kb) at 5q31 chromosomal region containing LRRTM2 has been shown to be related to intellectual disability and developmental delay.


== Disease ==
Some studies also show that LRRTM2 is also related to bipolar disorder.


A large number of researches shows that LRRTM2 is related to bipolar disorder.
A deletion (240 kb) at 5q31 chromosomal region containing LRRTM2 and CTNNA1 has been shown to be related to intellectual disability and developmental delay.


== References ==
== References ==
Line 90: Line 88:
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.13159
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.13159
https://www.rcsb.org/structure/5Z8X
https://www.rcsb.org/structure/5Z8X
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066302/pdf/nihms258120.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913944/pdf/2040-2392-1-7.pdf
https://espace.library.uq.edu.au/view/UQ:313747